+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dental Biomaterials Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • PDF Icon


  • 114 Pages
  • April 2023
  • Region: Global
  • Mordor Intelligence
  • ID: 4896017
The dental biomaterials market is expected to register a CAGR of 6.8% over the forecast period.

The impact of the COVID-19 pandemic on the market was significant as several elective procedures, including dental treatments, were halted or postponed during the pandemic. In March 2020, the American Dental Association (ADA) recommended postponing all elective dental procedures until April 6, 2020, and providing emergency-only dental services to keep patients from burdening hospital emergency departments. This recommendation was updated on April 1, 2020, when the ADA advised offices to remain closed except for urgent and emergency procedures until April 30, owing to the rising cases of COVID-19. As a result, access to dental care substantially decreased. Furthermore, as per data published by the British Dental Association, in July 2021, out of 2,053 dentists, only 36.0% were ready to resume dental practices in the United Kingdom. ​During the initial phase of the pandemic, dental services and treatments were delayed, which resulted in decreased demand for dental biomaterials and adversely impacted the market. However, with the resumption of dental services and with the decrease in the cases of COVID-19, the market started to gain traction and is expected to continue to grow over the forecast period.

The increasing burden of dental disorders and growing dental tourism, increasing penetration of dental implants, and increasing disposable income across developing countries are the major drivers for the market. The growing burden of dental diseases such as periodontal disease, tooth decay, oral cancer, halitosis, and dental caries, among other diseases, is driving the market growth. For instance, as per a March 2021 update by the WHO, it is estimated that oral diseases affect nearly 3.5 billion people globally, especially severe periodontal (gum) disease. Furthermore, according to a research article published in Dentaly.org in December 2021, the dental implant tourism is a growing business attributed to cost savings. Therefore, such a scenario may increase the demand for dental biomaterials owing to which considerable market growth is expected over the forecast period.

Furthermore, as per a March 2022 update by the WHO, severe periodontal (gum) disease, which may result in tooth loss, is also prevalent, affecting almost 10.0% of the global population. Adding to that, as per the NHS Dental Statistics for England 2021 report, 18.2 million adults were seen by an NHS Dentist in the 24 months up to June 2021. In addition, as per the same source, 3.9 million children were seen by an NHS dentist in the 12 months up to June 2021. Moreover, increasing product launches by the key players are also surging the market growth. For instance, in May 2021, Botiss launched a next generation dental biomaterial, NOVAMag regeneration system. The product provides an option for those dentists seeking a biomaterial that is mechanically strong but completely resorbable and is replaced with bone over time. Thus, the increasing prevalence of dental diseases and product launches by the key players may create opportunities for the market owing to which considerable market growth is expected over the forecast period.

However, regulatory issues and high cost of procedures may restrain the market growth over the forecast period.

Dental Biomaterials Market Trends

Titanium Biomaterials Segment is Expected to Witness Considerable Growth over the Forecast Period

Titanium biomaterials are a central class of materials for use in dental treatments. This can be attributed to the high strength and other mechanical properties associated with this material. Currently, biomaterials are made up of metals and alloys, polymers, ceramics, and composites. Among them, implanted materials made up of titanium are regarded as the most useful medical devices. Titanium is considered inert and safe for human use. It causes minimal side effects in the human body. Thus, owing to such advantages, titanium biomaterials are widely used as metallic biomaterials for dental procedures.

​The advantages of titanium biomaterials and increasing dental visits are the major drivers for the segment. For instance, according to the research article published in November 2021, titanium alloys are widely used for dental and implant materials due to their superior biocompatibility, corrosion resistance, and mechanical strength compared with other metallic and non-metalic implant materials. Similarly, as per the article published in August 2021, Ti-Ga-Si is considered to combine the advantages of the Ti-Ga alloy along with Si, which enhances osseointegration with aesthetically pleasing outcomes for patients and minimal likelihood of medical complications. Furthermore, according to an NCBI study published in June 2021, the alloys cpTi and Ti-6Al-4V are highly satisfactory materials and should be used for dental implants. Such studies indicate the efficacy of titanium biomaterials and are expected to generate significant demand for titanium biomaterials, thus positively impacting the segment’s growth.​ The product launches by the key players are also expected to create opportunities for segment growth. For instance, in July 2021, NuVasive launched Modulus ALIF, a 3D-printed porous titanium implant for anterior lumbar interbody fusion (ALIF), in targeted global regions. Therefore, owing to the advantages of titanium biomaterials, product launches by key players, and increasing dental visits, considerable segment growth is anticipated over the forecast period.

North America is Expected to Witness Significant Growth Over the Forecast Period

North America is expected to witness considerable growth over the forecast period. The growth is due to the factors such as the increase in product launches supported by government authorities, the rising burden of dental diseases, and the increasing geriatric population bolstering the demand for dental biomaterials in the region. For instance, as per the American Dental Association, in 2021, more than 5.0 million seniors aged 65 to 74 in the United States had complete tooth loss, with nearly 3.0 million suffering from edentulous. Tooth loss, on the other hand, is primarily a problem for the elderly population. This is because 91.0% of adults aged 20 to 64 have dental caries, with a staggering 27.0% going untreated. Furthermore, tooth decay is a common cause of tooth loss in many cases. Thus, such factors are anticipated to boost the total dental procedures performed across North America, thereby boosting the demand for dental biomaterials within the region.

Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and increasing dental visits in the United States are some of the factors driving the growth of the dental biomaterials market in the country. ​Furthermore, several market players are also engaged in implementing strategic initiatives, thereby propelling market growth. For instance, in January 2020, Pulpdent Corporation, a dental research, and manufacturing company based in the Greater Boston area, launched its ACTIVA Presto dental material. The new white dental filling material mimics the properties of natural teeth. Similarly, in September 2020, Ditron Dental USA, the United States affiliate of Ditron Dental, started its commercial operations for its dental implant portfolio in the country. Therefore, owing to the product launches in the country the market is expected to witness significant growth over the forecast period.

Dental Biomaterials Market Competitor Analysis

The dental biomaterials market is moderately competitive, with the presence of local and international players in the market. The major share of the market has been grabbed by global players, whereas small to mid-sized companies are posing intense competition with the help of novel technologies. In the future, it is expected that the market share will be distributed among international players and small players as well due to the focus on new entrants to come up with innovative products. Some of the major players in the market are Straumann Holding AG, Dentsply Sirona Inc., 3M Company, ZimVie Inc., and Botiss Biomaterials GmbH among others.

Additional benefits of purchasing the report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Dental Disorders and Growing Dental Tourism
4.2.2 Increasing Penetration of Dental Implants
4.2.3 Increase in Disposable Incomes across Developing Countries
4.3 Market Restraints
4.3.1 Regulatory Issues and High Cost of the Procedures
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD Million)
5.1 By Type
5.1.1 Metallic Biomaterials Titanium Stainless Steel Chromium Alloys Other Metallic Biomaterials
5.1.2 Ceramic Biomaterials
5.1.3 Polymeric Biomaterials
5.1.4 Natural Biomaterials
5.1.5 Other Types
5.2 By Application
5.2.1 Orthodontics
5.2.2 Prosthodontics
5.2.3 Other Applications
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Academies and Research Institutes
5.3.3 Other End Users
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 GC Corporation
6.1.2 Victrex PLC
6.1.3 Medtronic PLC
6.1.4 Straumann Holding AG
6.1.5 ZimVie Inc.
6.1.6 Dentsply Sirona Inc.
6.1.7 Royal DSM
6.1.8 Danaher Corporation
6.1.9 3M Company
6.1.10 Bay Materials
6.1.11 Vannini Dental Industry SRL
6.1.12 Kyocera Corporation
6.1.13 Botiss Biomaterials GmbH

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • GC Corporation
  • Victrex PLC
  • Medtronic PLC
  • Straumann Holding AG
  • ZimVie Inc.
  • Dentsply Sirona Inc.
  • Royal DSM
  • Danaher Corporation
  • 3M Company
  • Bay Materials
  • Vannini Dental Industry SRL
  • Kyocera Corporation
  • Botiss Biomaterials GmbH